Enhancing Critical Thinking Competency and Nursing Quality in Critically Ill Patient Care
Enhancing Critical Thinking Competency and Nursing Quality in Critically Ill Patient Care: A Quasi-Experimental Study of an Evidence-Based Nutritional Management Protocol
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jiangsu
-
Taizhou, Jiangsu, China, 225300
- Taizhou Hospital of Traditional Chinese Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosis of critical illness by attending physicians or higher-qualified specialists according to established critical care diagnostic standards
- requirement for ICU admission with full access to standardized critical care and medical resources
- preserved partial gastrointestinal function without severe intestinal obstruction or perforation confirmed by certified nutritionists or senior nurses, enabling potential enteral nutrition (EN) or combined EN-parenteral nutrition (PN) support.
Exclusion Criteria:
- patients with severe cognitive impairment or psychiatric instability (e.g., advanced dementia, schizophrenia, status epilepticus) impairing capacity to engage in nutritional assessments or adhere to clinical protocols, which would jeopardize data collection reliability
- terminal-stage conditions (malignancies, renal/hepatic failure) with life expectancy < 7 days or exclusively receiving palliative care, leading to misalignment between their palliative nutritional goals and the study's therapeutic intervention objectives
- congenital metabolic disorders (e.g., phenylketonuria) or short bowel syndrome requiring specialized nutritional protocols, which were incompatible with conventional critical care nutritional protocols and could compromise the generalizability of study findings
- pregnancy/lactation due to unique nutritional demands and potential risks to fetal/infant development inherent in the study design, contravening established ethical standards
- cases involving transfer, voluntary discharge, or withdrawal of consent that compromised data completeness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Conventional group
The conventional group adhered to conventional nutritional management methods and training
|
The conventional group adhered to conventional nutritional management methods and training
|
|
Other: Evidence-based nursing group
The study group implemented the EBN-based protocol alongside structured training
|
The study group implemented the EBN-based protocol alongside structured training
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement in Junior Nurses' Specialized Critical Thinking Competency
Time Frame: Baseline: Before training (Day 0). Post-intervention: 3 months after protocol implementation.
|
Change in critical thinking scores measured by the Chinese Critical Thinking Disposition Inventory (CTDI-CV), a 70-item scale evaluating 7 dimensions (truth-seeking, open-mindedness, analyticity, systematicity, self-confidence, inquisitiveness, cognitive maturity) on a 6-point Likert scale.
Higher scores indicate superior competency.
|
Baseline: Before training (Day 0). Post-intervention: 3 months after protocol implementation.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum Albumin Levels
Time Frame: ICU admission (Day 0) and Day 14.
|
Objective nutritional biomarker (g/L) measured via venous blood sampling.
|
ICU admission (Day 0) and Day 14.
|
|
Serum Prealbumin Levels
Time Frame: Day 0 and Day 14.
|
Short-term nutritional status marker (mg/L) assessed alongside albumin.
|
Day 0 and Day 14.
|
|
Patient Satisfaction
Time Frame: Day 15.
|
Self-reported satisfaction rated on a 5-point Likert scale (1: extremely dissatisfied, 5: extremely satisfied).
|
Day 15.
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Aspiration
Time Frame: Daily monitoring until Day 14
|
Binary outcome (yes/no) recorded during EN/PN administration.
|
Daily monitoring until Day 14
|
|
Incidence of Diarrhea
Time Frame: Daily monitoring until Day 14.
|
Defined as ≥3 loose stools/day, documented by nurses.
|
Daily monitoring until Day 14.
|
|
Incidence of Abdominal Distension
Time Frame: Daily monitoring until Day 14.
|
Assessed via physical examination and patient reporting.
|
Daily monitoring until Day 14.
|
|
Body Weight Changes
Time Frame: Day 0 and Day 14.
|
Measured in kg (bedside scales for ambulatory patients; estimated for others).
|
Day 0 and Day 14.
|
|
Blood Glucose Fluctuations Description: Time Frame:
Time Frame: Daily until Day 14
|
Capillary/venous glucose levels (mmol/L) monitored per ICU protocol.
|
Daily until Day 14
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- No. 20240625
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.